Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

Mount Marty University will launch the region’s first Graduate Regulatory Science Program to train future leaders in the ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...